Literature DB >> 12482550

Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study.

Paul F Jacques1, Andrew G Bostom, Jacob Selhub, Sharron Rich, R Curtis Ellison, John H Eckfeldt, Roy A Gravel, Rima Rozen.   

Abstract

The metabolism of homocysteine requires contributions of several enzymes and vitamin cofactors. Earlier studies identified a common polymorphism of methylenetetrahydrofolate reductase that was associated with mild hyperhomocysteinemia. Common variants of two other enzymes involved in homocysteine metabolism, methionine synthase and methionine synthase reductase, have also been identified. Methionine synthase catalyzes the remethylation of homocysteine to form methionine and methionine synthase reductase is required for the reductive activation of the cobalamin-dependent methionine synthase. The methionine synthase gene (MTR) mutation is an A to G substitution, 2756A-->G, which converts an aspartate to a glycine codon. The methionine synthase reductase gene (MTRR) mutation is an A to G substitution, 66A-->G, that converts an isoleucine to a methionine residue. To determine if these polymorphisms were associated with mild hyperhomocysteinemia, we investigated subjects from two of the NHLBI Family Heart Study field centers, Framingham and Utah. Total plasma homocysteine concentrations were determined after an overnight fast and after a 4-h methionine load test. MTR and MTRR genotype data were available for 677 and 562 subjects, respectively. The geometric mean fasting homocysteine was unrelated to the MTR or MTRR genotype categories (AA, AG, GG). After a methionine load, a weak positive association was observed between change in homocysteine after a methionine load and the number of mutant MTR alleles (P-trend=0.04), but this association was not statistically significant according to the overall F-statistic (P=0.12). There was no significant interaction between MTR and MTRR genotype or between these genotypes and any of the vitamins with respect to homocysteine concentrations. This study provides no evidence that these common MTR and MTRR mutations are associated with alterations in plasma homocysteine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12482550     DOI: 10.1016/s0021-9150(02)00204-6

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  22 in total

1.  Polymorphisms in methionine synthase reductase and betaine-homocysteine S-methyltransferase genes: risk of placental abruption.

Authors:  Cande V Ananth; Denise A Elsasser; Wendy L Kinzler; Morgan R Peltier; Darios Getahun; Daniel Leclerc; Rima R Rozen
Journal:  Mol Genet Metab       Date:  2007-03-26       Impact factor: 4.797

2.  The methionine synthase reductase 66A>G polymorphism is a maternal risk factor for spina bifida.

Authors:  Ivon J M van der Linden; Martin den Heijer; Lydia A Afman; Henkjan Gellekink; Sita H H M Vermeulen; Leo A J Kluijtmans; Henk J Blom
Journal:  J Mol Med (Berl)       Date:  2006-10-06       Impact factor: 4.599

3.  Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.

Authors:  Souhir Chaabane; Sameh Marzouk; Rim Akrout; Mariem Ben Hamad; Yosser Achour; Ahmed Rebai; Leila Keskes; Hela Fourati; Zouhir Bahloul; Abdellatif Maalej
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-08       Impact factor: 2.441

4.  Polymorphisms in methionine synthase, methionine synthase reductase and serine hydroxymethyltransferase, folate and alcohol intake, and colon cancer risk.

Authors:  Susan E Steck; Temitope Keku; Lesley M Butler; Joseph Galanko; Beri Massa; Robert C Millikan; Robert S Sandler
Journal:  J Nutrigenet Nutrigenomics       Date:  2008-06-02

5.  Alcohol consumption and genetic variation in methylenetetrahydrofolate reductase and 5-methyltetrahydrofolate-homocysteine methyltransferase in relation to breast cancer risk.

Authors:  Mary E Platek; Peter G Shields; Catalin Marian; Susan E McCann; Matthew R Bonner; Jing Nie; Christine B Ambrosone; Amy E Millen; Heather M Ochs-Balcom; Sylvia K Quick; Maurizio Trevisan; Marcia Russell; Thomas H Nochajski; Stephen B Edge; Jo L Freudenheim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08-25       Impact factor: 4.254

6.  Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation.

Authors:  Jane C Figueiredo; A Joan Levine; Maria V Grau; Oivind Midttun; Per M Ueland; Dennis J Ahnen; Elizabeth L Barry; Shirley Tsang; David Munroe; Iqbal Ali; Robert W Haile; Robert S Sandler; John A Baron
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

7.  Polygenic association with total homocysteine in the post-folic acid fortification era: the CARDIA study.

Authors:  Michael Y Tsai; Catherine M Loria; Jing Cao; Yongin Kim; David S Siscovick; Pamela J Schreiner; Naomi Q Hanson
Journal:  Mol Genet Metab       Date:  2009-06-06       Impact factor: 4.797

Review 8.  One-carbon metabolism and breast cancer: an epidemiological perspective.

Authors:  Xinran Xu; Jia Chen
Journal:  J Genet Genomics       Date:  2009-04       Impact factor: 4.275

9.  Effects of methionine synthase and methylenetetrahydrofolate reductase gene polymorphisms on markers of one-carbon metabolism.

Authors:  Vikki Ho; Thomas E Massey; Will D King
Journal:  Genes Nutr       Date:  2013-10-08       Impact factor: 5.523

10.  Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism.

Authors:  Petra Bohanec Grabar; Dusan Logar; Boris Lestan; Vita Dolzan
Journal:  Eur J Clin Pharmacol       Date:  2008-07-08       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.